Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 23)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Feb-10 Reuters Investment Profile N/A Novartis AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public COSMETICS & PERSONAL CARE Companies - Graham & Whiteside listing 5 $45 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public MANUFACTURING Companies - Graham & Whiteside listing 36 $220 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public BIOTECHNOLOGY Companies - Graham & Whiteside listing 7 $80 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public HEALTHCARE Companies - Graham & Whiteside listing 12 $110 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public CHEMICALS Companies - Graham & Whiteside listing 17 $110 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public PHARMACEUTICALS Companies - Graham & Whiteside listing 10 $80 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public CONGLOMERATES Companies - Graham & Whiteside listing 34 $220 View Abstract
Next 13

Brokerage Reports (Showing 1 to 2 of 2)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Mar-09 Roth Capital Partners, Inc. N/A Morning Call Summary 13 $60 View Abstract
20-Mar-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Daytrana Recall Expected, In Guidance 3 $12 View Abstract

Independent Reports (Showing 1 to 10 of 21)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
6-Feb-10 Reuters Investment Profile N/A Novartis AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public COSMETICS & PERSONAL CARE Companies - Graham & Whiteside listing 5 $45 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public MANUFACTURING Companies - Graham & Whiteside listing 36 $220 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public BIOTECHNOLOGY Companies - Graham & Whiteside listing 7 $80 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public HEALTHCARE Companies - Graham & Whiteside listing 12 $110 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public CHEMICALS Companies - Graham & Whiteside listing 17 $110 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public PHARMACEUTICALS Companies - Graham & Whiteside listing 10 $80 View Abstract
1-Feb-10 Graham & Whiteside Limited Graham & Whiteside SWITZERLAND - Public CONGLOMERATES Companies - Graham & Whiteside listing 34 $220 View Abstract
Next 11

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.